MANGOCEUTICALS, INC. Reports Director and Officer Changes
Ticker: MGRX · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1938046
| Field | Detail |
|---|---|
| Company | Mangoceuticals, INC. (MGRX) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
Mangoceuticals just filed an 8-K: new directors and officers appointed, with compensation details.
AI Summary
On July 1, 2025, MANGOCEUTICALS, INC. filed an 8-K report detailing changes in its board of directors and executive officers. The filing includes information on the election of new directors and the appointment of certain officers, along with details regarding compensatory arrangements for these key individuals. The company, incorporated in Texas with its principal executive offices in Dallas, is involved in health and allied services.
Why It Matters
Changes in a company's board and executive team can signal shifts in strategy, governance, or operational focus, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty and signal potential strategic shifts, warranting closer investor scrutiny.
Key Players & Entities
- MANGOCEUTICALS, INC. (company) — Registrant
- July 1, 2025 (date) — Date of Earliest Event Reported
- Texas (location) — State of Incorporation
- Dallas (location) — Principal Executive Offices City
- 15110 N. Dallas Parkway , Suite 600 (address) — Principal Executive Offices Street
- 75248 (zip_code) — Principal Executive Offices Zip Code
- (214) 242-9619 (phone_number) — Registrant's telephone number
FAQ
What specific changes were made to the board of directors and officer positions?
The 8-K filing indicates the election of directors and the appointment of certain officers, though specific names and exact positions are not detailed in the provided excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on July 1, 2025.
Where is MANGOCEUTICALS, INC. incorporated and where are its principal executive offices located?
MANGOCEUTICALS, INC. is incorporated in Texas, and its principal executive offices are located in Dallas, Texas, at 15110 N. Dallas Parkway, Suite 600, 75248.
What is the company's IRS Employer Identification Number (EIN)?
The company's IRS Employer Identification Number (EIN) is 87-3841292.
What is the SIC code for MANGOCEUTICALS, INC.?
The Standard Industrial Classification (SIC) code for MANGOCEUTICALS, INC. is 8090, which falls under SERVICES-MISC HEALTH & ALLIED SERVICES, NEC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 regarding MANGOCEUTICALS, INC. (MGRX).